Market capitalization | €788.49m |
Enterprise Value | €1.13b |
P/E (TTM) P/E ratio | 13.25 |
EV/Sales (TTM) EV/Sales | 0.47 |
P/S ratio (TTM) P/S ratio | 0.33 |
P/B ratio (TTM) P/B ratio | 0.73 |
Dividend yield | 3.60% |
Last dividend (FY23) | €8.00 |
Revenue growth (TTM) Revenue growth | 1.25% |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
Jun '24 |
+/-
%
|
||
Revenue | 2,383 2,383 |
1%
1%
|
|
Gross Profit | 625 625 |
5%
5%
|
|
EBITDA | 214 214 |
34%
34%
|
EBIT (Operating Income) EBIT | 110 110 |
95%
95%
|
Net Profit | 60 60 |
156%
156%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following business segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization. The Incontinence Management segment provides incontinence hygiene, medical records, and products for patient and medical skin care. The Infection Management segment consists of surgery sets, surgical clothing, and surgical examination gloves. The Other Group Activities segment focuses on the areas of cotton wool products, feminine hygiene, baby hygiene, medical consumer goods, medicated and dietary supplements, body care and bath products, and commercial business. The company was founded in 1818 and is headquartered in Heidenheim, Germany.
Head office | Germany |
CEO | Britta Fuenfstueck |
Employees | 10,168 |
Founded | 1818 |
Website | www.hartmann.info |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.